Self-Management of Blood Pressure in Resistant Hypertension
ConditionResistant Hypertension
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTaichung Veterans General Hospital
About this trial
The trial is a 12-month randomized, parallel-group study comparing three arms: (1) HBP self-management with AI chatbot support, (2) HBP self-management without AI chatbot support, and (3) usual care. The primary objective is to evaluate differences in blood pressure changes and medication compliance between groups at 6 and 12 months.
Eligibility criteria
Qualifiers
≥18 years of age
receiving ≥3 antihypertensive medications of different classes, including a diuretic, and baseline BP >130/80 mmHg; or receiving ≥ 4 medications regardless of BP
Disqualifiers
unable to conduct self-monitor BP because of cognitive dysfunction
poor adherence to medication
poor digital capabilities
pregnant
Trial design
Treatments tested in this trial
- AI chatbot support
- telemonitoring and case management
Treatment groups
600 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov